Globe Newswire
La Paz, Baja California Sur, Mexico, May 23, 2024 (GLOBE NEWSWIRE) -- La Paz, Baja California Sur, Mexico, May 23, 2024 – Nestled on the shores of the Sea of Cortez, La Paz, the capital of Baja California Sur, is emerging as a premier destination for travelers seeking relaxation and wellness experiences. With its stunning natural beauty, tranquil beaches, and laid-back atmosphere, La Paz offers the perfect setting to unwind and rejuvenate.Known for its crystal-clear... (continue reading...)
FORM 8.3
PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)Name of offeror/offeree in... (continue reading...)Oslo, Norway, 23 May 2024
Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in the call for the annual general meeting, including the proposal to distribute a dividend of total NOK 1 per share, to be paid partly in June (NOK 0.5) and November (NOK 0.5).
For the June dividend of NOK 0.5 per share, the shares will be traded excluding the right (ex-date)... (continue reading...)
FORM 8.3
PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)Name of offeror/offeree in... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient.... (continue reading...)More Globe Newswire
View Older Stories-
Trexo Robotics Partners with KidsPhysio to Enhance Access to Innovative Physiotherapy Solutions for Children
-
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
-
Brain Cancer Canada Awards an $80,000 research grant to the development of dual function therapies that harness the body's own immune system to kill brain tumour cells in glioblastomas
-
Foremost Lithium Successfully Completes its Winter Drill Program at its Zoro Lithium Project in Manitoba, Canada
-
Cloud Infrastructure Service Market Expected to Reach $282 Billion By 2033
-
OptimumBank Holdings, Inc. To Hold Annual Shareholder Meeting and Investor Day, Wednesday, May 29, 2024 at its Headquarters in Ft. Lauderdale, Florida
-
Invesco Ltd: Form 8.3 - DS Smith PLC Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Anglo American PLC
-
Euroseas Ltd. Reports Results for the Quarter Ended March 31, 2024 and Declares Quarterly Common Stock Dividend
-
NORBIT – Award and exercise of restricted stock units
-
Form 8.3 - Keywords Studios plc
-
Form 8.3 - [MATTIOLI WOODS PLC - 22 05 2024] - (CGWL)
-
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
-
Navios Maritime Holdings Inc.’s Tender Offer Deadline is midnight on June 7, 2024 to receive $4.75 in Cash for All Holders of ADSs (Series G & H)
-
Form 8.3 - [LOK'N STORE GROUP PLC - 22 05 2024] - (CGWL)
-
Navios Maritime Holdings Inc.’s Tender Offer Deadline is midnight on June 7, 2024 to receive $4.75 in Cash for All Holders of ADSs (Series G & H)
-
Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
-
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
-
Ashvattha Therapeutics to Present Preclinical Data at the CMSC and SNMMI Annual Meetings
-
IO Biotech to Present at Jefferies Global Healthcare Conference
-
Saratoga Investment Corp. Increases Quarterly Dividend by $0.01, or 1.4%, to $0.74 per Share for the Fiscal First Quarter Ended May 31, 2024
-
NANO Nuclear Energy, the First Portable Nuclear Microreactor Publicly Listed in the U.S., Pledges Support to the World Nuclear Association’s Net Zero Nuclear Industry Initiative
-
Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More C
-
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
-
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
-
Colonial Electric Supply Chooses Bridgeline’s AI-Powered HawkSearch on Optimizely
-
ETR Survey Highlights Urgent Need for Expertise in Leveraging Generative AI on Unstructured Data
-
KULR CEO Michael Mo Reduces Cash Salary to Better Align with Shareholder Value Creation
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 22 05 2024] - (CGWL)
-
Mint Income Fund Announces Normal Course Issuer Bid
-
Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
-
FluxOS Breaks Barriers, Introduces Fiat Payments OnRamp Solution with PayPal
-
Form 8.3 - AXA INVESTMENT MANAGERS: Spirent Communications plc
-
Navios South American Logistics Inc. Reports Financial Results for the First Quarter Ended March 31, 2024
-
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
-
Landsbankinn hf.: Covered bond exchange offering results
-
Meltwater launches content creator program for Communications, Marketing and PR professionals
-
REPEAT – Media Conference - Update: Fightback to Save Durham Hospital Ratcheting Up
-
Alliance Trust PLC - Net Asset Value
-
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
-
Greenridge Exploration Announces Increase in Land Position at Nut Lake Project with 10.4% U3O8 & 5.51% Cu
-
Mission Produce™ to Release Fiscal Second Quarter 2024 Financial Results on Thursday, June 6, 2024
-
MKS Instruments to Participate in BofA Securities Global Technology Conference
-
NV5 Awarded $12 Million in Federal Defense and Intelligence Geospatial Contracts
-
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
-
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
-
Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
-
LifeVantage To Participate in Upcoming Investor Conferences
-
XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US
-
Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical